Flagship explainer
What drives Zomedica Corp.’s return on equity?
ROE is five filed business factors multiplied together.
| Input | Value | Fiscal year | Source |
|---|---|---|---|
| −$81.9M | FY2025 |
| |
| Income before tax | −$82.1M | FY2025 |
|
| Operating income | −$84.4M | FY2025 |
|
| $32M | FY2025 |
| |
| Ending assets | $127M | FY2025 |
|
| Beginning assets | $207M | FY2024 |
|
| $115M | FY2025 |
| |
| $196M | FY2024 |
|
Source:
- SEC filingFiling detailsAccession 0001104659-26-028450